Position in RXRX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$127,371,497
+$39,905,239 QoQ
Shares Held
34,706,130
+21.8% QoQ
Ownership
6.48%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 344 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 8%
Shared 0%
None 92%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. RXRX ranks #69 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,871,459 | $5,896,909,829 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,834,688 | $3,014,621,355 | |
| 3 | INCY |
Incyte Corp
|
9,722,336 | $1,102,124,008 | |
| 4 | MRNA |
Moderna, Inc.
|
15,726,193 | $1,101,305,295 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,555,689 | $1,070,369,059 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
4,897,051 | $917,119,711 | |
| 7 | RPRX |
Royalty Pharma plc
|
12,338,229 | $691,804,500 | |
| 8 | INSM |
INSMED Inc
|
6,052,174 | $645,282,791 |
All Filings in RXRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $127,371,497 | 34,706,130 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $87,466,258 | 28,490,638 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $103,615,601 | 25,333,888 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $89,152,354 | 18,268,925 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $56,568,467 | 11,179,539 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $69,221,014 | 13,085,258 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $85,029,713 | 12,578,360 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $84,815,092 | 12,870,272 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $65,621,902 | 8,749,587 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $103,212,989 | 10,352,356 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $119,815,229 | 12,151,646 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $89,941,723 | 11,757,088 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $42,563,552 | 5,697,932 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $42,504,675 | 6,372,515 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $60,685,086 | 7,870,958 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $48,473,275 | 4,555,759 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $17,303,458 | 2,125,732 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $13,738,135 | 1,918,734 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $79,769,733 | 4,656,727 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $37,839,806 | 1,644,494 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $13,776,268 | 377,432 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||